Steigerwald, Gordon & Koch Inc. Amgen Inc Transaction History

Steigerwald, Gordon & Koch Inc.

$884 Million
Q4 2024

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Amgen Inc stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 70,450 shares of AMGN stock, worth $20.1 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

70,450

Previous 70,016 0.62%

Holding current value

$20.1 Million

Previous $22.6 Million 18.6%

% of portfolio

2.08%

Previous 2.48%

53 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$258.78 - $328.31 $112,310 - $142,486	434 Added 0.62%	70,450 $18.4 Million
Q3 2024 Oct 09, 2024	BUY	$309.38 - $337.38 $455,716 - $496,960	1,473 Added 2.15%	70,016 $22.6 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $329,225 - $400,095	1,253 Added 1.86%	68,543 $21.4 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $251,124 - $303,139	934 Added 1.41%	67,290 $19.1 Million
Q4 2023 Jan 16, 2024	BUY	$255.7 - $288.46 $232,431 - $262,210	909 Added 1.39%	66,356 $19.1 Million
Q3 2023 Oct 11, 2023	BUY	$218.65 - $271.46 $299,769 - $372,171	1,371 Added 2.14%	65,447 $17.6 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $332,332 - $392,976	1,551 Added 2.48%	64,076 $14.2 Million
Q1 2023 Apr 19, 2023	BUY	$225.79 - $275.2 $368,715 - $449,401	1,633 Added 2.68%	62,525 $15.1 Million
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $228,342 - $290,136	997 Added 1.66%	60,892 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $265,985 - $299,982	1,185 Added 2.02%	59,895 $13.5 Million
Q2 2022 Jul 14, 2022	BUY	$230.71 - $256.74 $84,901 - $94,480	368 Added 0.63%	58,710 $14.3 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $176,073 - $194,783	803 Added 1.4%	58,342 $14.1 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $356,989 - $408,542	1,795 Added 3.22%	57,539 $12.9 Million
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $61,558 - $72,123	290 Added 0.52%	55,744 $11.9 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $333,318 - $369,792	1,427 Added 2.64%	55,454 $13.5 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $37,724 - $43,962	-170 Reduced 0.31%	54,027 $13.4 Million
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $165,530 - $197,117	765 Added 1.43%	54,197 $12.5 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $35,901 - $39,925	153 Added 0.29%	53,432 $13.6 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $96,729 - $118,699	489 Added 0.93%	53,279 $12.6 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $437,558 - $580,321	-2,401 Reduced 4.35%	52,790 $10.7 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $61,493 - $79,040	-325 Reduced 0.59%	55,191 $13.3 Million
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $13,406 - $16,063	77 Added 0.14%	55,516 $10.7 Million
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $6,834 - $8,011	-41 Reduced 0.07%	55,439 $10.2 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $136,195 - $153,521	-753 Reduced 1.34%	55,480 $10.5 Million
Q4 2018 Jan 18, 2019	BUY	$178.4 - $208.25 $34,252 - $39,984	192 Added 0.34%	56,233 $10.9 Million
Q3 2018 Oct 11, 2018	SELL	$185.29 - $208.89 $300,725 - $339,028	-1,623 Reduced 2.81%	56,041 $11.6 Million
Q2 2018 Sep 14, 2018	BUY	$166.05 - $186.51 $162,562 - $182,593	979 Added 1.73%	57,664 $10.6 Million
Q1 2018 Sep 14, 2018	SELL	$169.43 - $198.0 $234,829 - $274,428	-1,386 Reduced 2.39%	56,685 $9.66 Million
Q4 2017 Sep 14, 2018	SELL	$168.79 - $188.59 $540,634 - $604,053	-3,203 Reduced 5.23%	58,071 $10.1 Million
Q3 2017 Sep 14, 2018	BUY	$167.29 - $191.0 $35,632 - $40,683	213 Added 0.35%	61,274 $11.4 Million
Q2 2017 Sep 13, 2018	BUY	N/A	1,927 Added 3.26%	61,061 $10.4 Million
Q1 2017 Sep 13, 2018	BUY	N/A	2,550 Added 4.51%	59,134 $9.62 Million
Q4 2016 Sep 13, 2018	BUY	N/A	2,785 Added 5.18%	56,584 $8.18 Million
Q3 2016 Sep 13, 2018	BUY	N/A	627 Added 1.18%	53,799 $8.86 Million
Q2 2016 Sep 13, 2018	BUY	N/A	2,739 Added 5.43%	53,172 $7.97 Million
Q1 2016 Sep 13, 2018	BUY	N/A	568 Added 1.14%	50,433 $7.42 Million
Q4 2015 Sep 13, 2018	SELL	N/A	-147 Reduced 0.29%	49,865 $7.94 Million
Q3 2015 Sep 13, 2018	BUY	N/A	1,597 Added 3.3%	50,012 $6.78 Million
Q2 2015 Sep 13, 2018	BUY	N/A	587 Added 1.23%	48,415 $7.28 Million
Q1 2015 Sep 13, 2018	BUY	N/A	485 Added 1.02%	47,828 $7.49 Million
Q4 2014 Sep 13, 2018	SELL	N/A	-3,238 Reduced 6.4%	47,343 $7.41 Million
Q3 2014 Sep 13, 2018	SELL	N/A	-1,733 Reduced 3.31%	50,581 $6.99 Million
Q2 2014 Sep 13, 2018	BUY	N/A	2,406 Added 4.82%	52,314 $6.1 Million
Q1 2014 Sep 13, 2018	BUY	N/A	2,973 Added 6.33%	49,908 $6.11 Million
Q4 2013 Sep 13, 2018	BUY	N/A	5,214 Added 12.5%	46,935 $5.31 Million
Q3 2013 Sep 13, 2018	BUY	N/A	623 Added 1.52%	41,721 $4.63 Million
Q2 2013 Sep 13, 2018	BUY	N/A	4,911 Added 13.57%	41,098 $4.02 Million
Q1 2013 Sep 13, 2018	BUY	N/A	51 Added 0.14%	36,187 $3.67 Million
Q4 2012 Sep 13, 2018	SELL	N/A	-249 Reduced 0.68%	36,136 $3.08 Million
Q3 2012 Sep 13, 2018	SELL	N/A	-10,924 Reduced 23.09%	36,385 $3.03 Million
Q2 2012 Sep 13, 2018	SELL	N/A	-524 Reduced 1.1%	47,309 $3.41 Million
Q1 2012 Sep 13, 2018	SELL	N/A	-458 Reduced 0.95%	47,833 $3.21 Million
Q4 2011 Sep 13, 2018	BUY	N/A	48,291	48,291 $3.07 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Amgen Inc Transaction History